cisplatin + etoposide + ifosfamide + valproic acid + vincristine

This is a multi-agent chemotherapy regimen composed of five drugs: - **Cisplatin** is a platinum-based chemotherapeutic that forms DNA crosslinks, leading to apoptosis in rapidly dividing cells. - **Etoposide** is a topoisomerase II inhibitor that causes DNA strand breaks and prevents cell division. - **Ifosfamide** is an alkylating agent that interferes with DNA replication and transcription by forming covalent bonds with DNA. - **Valproic acid** is primarily an anticonvulsant and mood stabilizer, but also acts as a histone deacetylase (HDAC) inhibitor, inducing cell cycle arrest and apoptosis in cancer cells[3][1][10]. It has been investigated for its anti-proliferative effects in oncology. - **Vincristine** is a vinca alkaloid antineoplastic agent that binds to tubulin, inhibiting microtubule formation, thereby arresting mitosis at metaphase[2][5][7]. This combination may be used experimentally or off-label for the treatment of refractory or relapsed cancers such as neuroblastoma or other solid tumors. The inclusion of valproic acid aims to overcome drug resistance mechanisms by modulating gene expression through HDAC inhibition[1][3].